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Ras interacts with numerous downstream effectors to
transmit a diverse array of cellular signals. A new
study shows that a protein known as Impedes Mito-
genic signal Propagation, IMP, is an E3 ubiquitin
ligase that binds Ras and modulates MAP kinase sig-
naling by regulating the scaffolding activity of KSR.
The Ras pathway is an essential signal transduction
cascade that controls cell survival, growth, differentia-
tion and transformation. Regulation of the plasma-
membrane-bound Ras GTPase is conceptually simple
— Ras acts as a molecular switch that is ‘on’ when
bound to GTP and ‘off’ when bound to GDP [1]. The
signaling responses induced by Ras activation are
highly varied, however, due largely to the myriad effec-
tor molecules that bind Ras in its GTP-bound state,
such as the MAP kinase kinase kinase Raf-1, the Ral
guanine nucleotide dissociation stimulator (RalGDS),
phosphatidylinositol 3-kinase, phospholipase Ce, the
Ras inhibitor RIN1, and the polarity protein AF6/Canoe
[2,3]. Now, with the discovery of Impedes Mitogenic
signal Propagation (IMP), another layer of regulatory
complexity for this important signaling cascade has
been revealed. In a recent study published in Nature by
Matheny and colleagues [4], IMP is identified as a Ras-
binding protein that modulates the signaling capacity of
a key Ras effector cascade, namely the Raf–MEK–ERK
kinase cascade.
IMP was isolated in a yeast two-hybrid screen for
proteins that interact with activated Ras, where binding
was specific for Ras and not observed with other Ras
family members. IMP is also known as BRAP2 and was
originally discovered as a protein that associates with
the nuclear localization motifs of the breast cancer
tumor suppressor protein BRCA1 [5]; however, the
functional significance of this interaction is unknown.
IMP is a ubiquitously expressed, highly conserved
protein, with one ortholog present in all eukaryotes
examined [4,5]. All IMP proteins contain three con-
served structural motifs — a RING-H2 domain followed
by a ubiquitin-protease-like zinc finger (UBP-ZnF; also
known as a PAZ domain) and leucine heptad repeats
that are predicted to form a coiled coil. As would be
expected for a Ras effector, Matheny et al. [4] found
that IMP binds to Ras in a GTP-dependent and stimu-
lus-dependent manner. Interestingly, however, IMP
does not possess a classical Ras-binding domain or
Ras-association domain found in many Ras-binding
partners and instead is reported to interact with Ras
through a region encompassing the UBP-ZnF domain.
When Matheny and coworkers [4] examined the
effect of IMP on Ras signaling, they found that instead
of cooperating with other effectors to promote Ras sig-
naling, IMP appeared to inhibit signal transmission
through the Raf–MEK–ERK cascade. Overexpression of
IMP blocked Raf-dependent activation of MEK and
ERK without preventing activation of Raf itself; this inhi-
bition could be circumvented by constitutively active
MEK. IMP overexpression also prevented the mitogen-
induced association of Raf and MEK, indicating that
high IMP levels had uncoupled Raf from its down-
stream substrate. Providing further evidence that IMP
was an antagonist of Raf-1 signaling, depletion of IMP
in mammalian cells increased the amplitude of stimu-
lus-induced ERK activation. Thus, IMP can be added to
the growing list of molecules that negatively regulate
Raf–MEK–ERK signaling, a list that already includes the
Raf kinase inhibitor protein RKIP [6], RIN1 [7] and
Sprouty/SPRED [8,9].
Surprisingly, the inhibitory effect of IMP was not
mediated by a direct interaction with Raf, MEK or ERK.
Matheny and coworkers [4] found no evidence that IMP
associated with or ubiquitinated Raf, MEK or ERK, and
the cellular levels of these potential targets were un-
altered by IMP overexpression. Instead, IMP appears to
uncouple signal transmission from Raf to MEK by inac-
tivating an important scaffolding protein of the Ras
pathway, namely the kinase suppressor of Ras (KSR)
[10–12]. In normal unstimulated cells, KSR constitutively
associates with MEK and is retained in the cytoplasm
through the binding of a dimer of 14-3-3 proteins to two
phosphoserine sites [13]. In response to stimulus, the
protein phosphatase PP2A dephosphorylates one of
these sites, resulting in the release of 14-3-3, the rapid
translocation of KSR to the plasma membrane, and
exposure of KSR’s MAP kinase binding site [14]. The
end result is that KSR delivers MEK to activated Raf at
the plasma membrane, provides a docking platform for
ERK, and facilitates the sequential phosphorylation
events required for ERK activation.
Evidence that KSR is the target of IMP’s inhibitory
effect was obtained using fibroblasts from KSR-defi-
cient mice [15]. Reintroduction of exogenous KSR into
these cells leads to enhanced levels of stimulus-
induced ERK activation, which is completely abol-
ished by IMP overexpression. IMP associates with
KSR and, when overexpressed, causes hyperphos-
phorylation and mislocalization of KSR into a deter-
gent-insoluble fraction. These effects resemble those
observed previously for an inactive KSR mutant that is
unable to bind MEK [16]. Further investigation is
needed to determine how IMP binding causes the
hyperphosphorylation and mislocalization of KSR and,
in particular, whether IMP influences MEK binding to
KSR. Nonetheless, these findings suggest that IMP
may inactivate KSR by sequestering it in a cellular
compartment inaccessible to activators of KSR func-
tion (Figure 1).
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Importantly, the inhibitory effect of IMP is relieved by
activated Ras, which restores ERK signaling and correct
localization of KSR. The E3 ligase activity of IMP has
been implicated in this step, because activated Ras
stimulates the autoubiquitination of IMP and an IMP
mutant lacking E3 ligase activity acts as a constitutive
‘super-inhibitor’. One caveat is that constitutively acti-
vated Ras, and not stimulus-induced normal Ras, was
required for overcoming the effects of overexpressed
IMP in these studies. The ability of physiological levels
of Ras activation to overcome any inhibitory effects of
IMP therefore remains to be confirmed in normal cells.
Additional characterization might also reveal whether
Ras activation targets IMP for degradation or otherwise
interferes with the IMP–KSR interaction.
The overall conclusion from this new study is that
Ras activation has dual effector inputs on the ERK
cascade: initiating Raf activation while derepressing
KSR-dependent Raf–MEK complex formation (Figure
1). In this sense, IMP is likely to serve as a negative reg-
ulator that keeps Ras signaling in check until cells
receive an appropriate stimulus. IMP might thus
perform an important role in fine-tuning ERK cascade
activity, allowing cells to react to diverse stimuli with
greater sensitivity and fidelity. Yet to be resolved is
whether IMP has other functions and whether it influ-
ences signaling through other Ras effector cascades.
On a more global level, because IMP depletion allowed
cells to respond to suboptimal doses of an extracellu-
lar stimulus, IMP might also modulate the threshold
sensitivity of cells to stimulus. If so, then IMP may play
a critical role in allowing cells to adapt their response to
chronic or complex signaling cues, a real-life property
of cell signaling not easily explained by the simple
model of a GTPase ‘on/off’ switch.
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Figure 1. Model for the regulation of ERK signaling by IMP.
(A) In quiescent cells, KSR constitutively interacts with dimeric
14-3-3 and inactive MEK. KSR also associates with IMP, and
when IMP is overexpressed, KSR is hyperphosphorylated and
localized to a triton-insoluble cellular fraction, apparently inac-
tivating the scaffolding activity of KSR. (B) In stimulated cells,
Ras activation has dual effector inputs on the ERK cascade.
First, by recruiting cytoplasmic Raf to the plasma membrane,
Ras initiates the Raf activation process. Second, by recruiting
IMP, Ras relieves the inhibition on KSR, allowing KSR to
translocate to the plasma membrane and mediate complex for-
mation between Raf, MEK and ERK. Ras binding also stimu-
lates the autoubiquitination of IMP, which may target IMP for
degradation or interfere with the IMP–KSR interaction.
Ras
GDP
Raf-1
C1RBD
KSR
Ub
IMP
Ub
Ub
IMPRaf-1
PP
P
Triton-insoluble
KSR
ERK
ERK
Ras
GTP
MEK
MEK
Current Biology
A Quiescent cell
B Stimulated cell
14
-3-
3
14
-3-
3
14-3-3
14-3-3
